Key points are not available for this paper at this time.
Background Among persons in North America who are newly infected with the human immunodeficiency virus (HIV), the prevalence of transmitted resistance to antiretroviral drugs has been estimated at 1 to 11 percent.
Little et al. (Thu,) studied this question.